Page 13 - Clinical Testing News Today

A new Nature study aimed to predict clinical data of COVID-19 patients based on clinical outcomes.

In contrast to intramuscular vaccines, only nasal vaccines are able to block the virus in the nose by inducing local immunity in the nasal mucosa, i.e. the portal of entry and multiplication of the virus.

Team von TU und Meduni Wien will neues System zur Abklärung der Fitness des Herz-Kreislauf- und Lungensystems auf den Markt bringen.

Researchers from the University of Birmingham, U.K., have confirmed the speed, accuracy, and simplicity of a novel, a highly sensitive testing method for COVID-19 that can be deployed at entertainment venues, airport arrival terminals, and in remote settings where clinical testing laboratories are not available.

Lateral Flow Assays Market worth $10.2 billion by 2025

Orameds jab-free oral Covid-19 vaccine is one of many in the form of pills, powders, or sprays that may hit the market in the next few years, which could dramatically expand vaccine rollout and uptake. An Israeli team is preparing to start trials of what could be the first Covid-19

Профессор Сеченовского университета объяснил, почему утверждение вакцин по упрощенной схеме не влияет на их безопасность

  1906 год, Львов: «Без вести пропала восемнадцатилетняя Мария Чайковская, служанка. В воскресенье вышла в костел. Ее поиски у родственников в Голоско (историческая местность во ⦁ Львове — прим. перев.) последствий не дали. Есть опасения, что она стала жертвой своего юног�...

The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, today published consensus recommendations to aid in the design and validation of clinical CYP2D6 assays, promote standardization of testing across different laboratories and improve patient care

Results of the study for positive cerebrospinal fluid cultures, provides valuable strategies for preventing pathogens and improving evidence-based treatment.